Clinical trial Recruiting at 1 site Observational

Examining how COVID-19 changed pulmonary procedures

Official title: The Impact of COVID-19 on Pulmonary Procedures: A Nationwide Survey

Run by M.D. Anderson Cancer Center · NCT05022446 · Data updated 2026-11-12

This study looks at how doctors who treat lung conditions changed their procedures and staffing during the COVID-19 pandemic to see what worked best.

Quick facts

Study typeObservational
SexAll
Enrollment250 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedNovember 11, 2020
Main results expectedFebruary 2, 2027
Study endsFebruary 2, 2027
Registry record updatedAugust 10, 2026
Trial IDNCT05022446 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pulmonologists who are members of the American Association of Bronchology and Interventional Pulmonology or the American College of Chest Physicians.

Probably not a fit

Patients who are not pulmonologists or who do not belong to the specified professional organizations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the adaptations made by pulmonary procedural programs across the United States in response to the COVID-19 pandemic. It aims to assess changes in procedural practices, ambulatory operations, and provider staffing among pulmonologists. Participants will complete a survey that takes approximately 5-10 minutes, providing valuable insights into how these programs adjusted during the crisis. The findings may guide future practices and research efforts in pulmonary medicine during pandemics.

Why it matters

Potential benefit: If successful, this study could enhance the preparedness and response of pulmonary programs during future pandemics.

How similar studies have gone: While this study focuses on a specific adaptation to the COVID-19 pandemic, similar studies have shown success in assessing changes in medical practices during health crises.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP)
* These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership

Exclusion Criteria:

None

Where it's running

  • M D Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.